Search

everythinglearnresearchcommunity

for

Search:↓

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

New genes found linked to balding, may help develop future treatments.

Dutasteride-containing mesotherapy effectively treats female hair loss, improving density and thickness with minimal side effects.

Some alternative treatments for hair loss might work, but more research is needed.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Eating high glycemic foods and drinking milk may worsen acne by increasing insulin and IGF-1 levels.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

Metformin should be used for PCOS mainly in those with glucose intolerance, and has limited benefits for infertility or hirsutism.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Long-term use of a certain medication can worsen erectile function in aged rats by damaging penile muscle cells.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Menopause affects hair and skin; more research needed for treatment.

Diagnosing PCOS in teenagers is hard because its symptoms often look like normal puberty, and there's a need for better diagnosis methods and agreement on criteria.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

At least 87% of Indian men experience hair loss, with type II being most common and severity increasing with age.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

Diagnosing PCOS in teenagers should focus on signs of excess male hormones and not rely solely on ovarian ultrasound or irregular periods, and should be reassessed in adulthood.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

AR gene not major factor in female hair loss; different from male hair loss.

Higher fluoride levels may delay puberty in boys.

Many young Australian women think they have PCOS, but only a few are diagnosed correctly, causing unnecessary worry.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.